Fastforward Innovations Share Discussion Threads

[the accountant] 06/4/2017 09:53

Well found TT

[doodlebug4] 06/4/2017 09:25

Many thanks Trotters.

[lauders] 06/4/2017 08:48

Thank you TT!

[trotterstrading] 06/4/2017 08:41

Checkout LIFE RNS re DBC

[doodlebug4] 05/4/2017 12:51

Growth company investor FastForward Innovations Ltd (LON:FFWD) has sold off its holding in tech investor Blue Star Capital PLC (LON:BLU) a little over a month after acquiring it.

The sale of the shares at 0.12p a piece raised approximately £306,000 for FastForward after costs.

The firm received the 268.2mln shares on 2 March as payment from Blue Capital after it snapped up FastForward’s stake in SatoshiPay Ltd.

A third of those shares were originally locked in for three months, another third for six months and the final third locked in for nine months from admission.

Blue Star agreed to waive these agreements yesterday though, saying that the stock overhang “may have led to the share price of Blue Star underperforming̷0;whilst investors wait for each lock-in period to end”.

Blue Star chief executive used the disposal from FastForward as an opportunity to beef up his stake in his company. He acquired a further 4.2mln shares to take his total interest to 19.8mln, or 2.04% of the company.

“The carrying cost of the Blue Star investment is £117,630 and the disposal will result in realized profit of £188,133,̶1; said FastForward chief executive Lorne Abony.

“This is the first of what I hope will be several events in the medium term where we are able to both generate profits and successfully monetize investments within our portfolio and is a vindication of the board's long term strategic plan.”

proactiveinvestors.com

[tenniselbow] 05/4/2017 12:39

A profit is a profit many companies would like to make these margins will buy more at this level

[3rd eye] 05/4/2017 11:31

I see doodlebug continues to put out FAKE NEWS, what changes.

[doodlebug4] 05/4/2017 11:05

You obviously know more about company tax affairs than I do, so I'm glad you agree! "Smoke and mirrors" - exactly.:-)

[the accountant] 05/4/2017 10:58

Agree db4. Due to the timeframes involved here you have to think this was ffwd's plan from the outset.The rest is just smoke and mirrors.

[3rd eye] 05/4/2017 10:01

888ICB5 Apr '17 - 07:58 - 6614 of 6614 1 0
They have realised a decent profit on an investment but it does seem an odd way of going about it. Let's see what they do with the money.??????????????????

-----------------------------------------------------------------------------------------------------------------------------------------

Thats easy, use it for operational day to day business as they are nigh on skint.

Wont last long though.

Now we know why the chief honcho bailed out.

[doodlebug4] 05/4/2017 10:01

Just speculation on my part, but I can see why the company would prefer to realise a profit - however small - at the beginning of a new tax year rather than at the end of the previous tax year. End of FFWD's tax year on 31st March.

[888icb] 05/4/2017 07:58

They have realised a decent profit on an investment but it does seem an odd way of going about it. Let's see what they do with the money.

[flashheart] 05/4/2017 07:56

Could well be a 'clear the decks' regarding the early investments pre Lorne Abony. IF this is the case, maybe something Mr Dattels was at odds with????? Pure speculation on my part. Should be an interesting period coming up with new positive developments? Increase in the Nuuvera investment????

[lauders] 05/4/2017 07:50

Yes cottoner. Doesn't seem such a great result really. A profit is a profit but it all seems a bit odd to me. Perhaps FFWD see a better place to invest the money but a bit disappointed SatoshiPay did not generate even more profit than it did.

Time for the next RNS to come I think!

[cottoner] 05/4/2017 07:45

On the other hand:


On 1 March 2017, the Company and Blue Star entered into a sale and purchase agreement ("SPA") under the terms of which Blue Star has agreed to purchase 1,471 shares in SatoshiPay for a total consideration of €500,140 (approximately £425,119), equivalent to a price of €340 per SatoshiPay share. Sale of the Company's interest in SatoshiPay at a price of €340 per share represents an increase of 212.5% in value since the time of the Company's original investment in September 2015.

The consideration is to be satisfied entirely through the issue of 268,213,880 new shares of Blue Star (the "Consideration Shares") each at an implied price of 0.1585 pence per share, being the average mid-market price for the ten trading days prior to this announcement. Following issue of the Consideration Shares, the Company will be interested in approximately 21.7 per cent. of the enlarged share capital of Blue Star.


Today:

The Company announces that it has placed out its entire holding of 268,213,880 shares of Blue Star Capital PLC ("Blue Star") for a cash consideration (after costs) of £305,763.



So, they appear to have 'lost' 425,119 - 305,763 = £119,356 in the deal in just over a month.

[bdog51] 05/4/2017 07:38

Some positives from this: we made a decent profit and we now hold cash. Didn't take Lorne very long to sell the Blue Star holding after the lock-in was lifted! I'm a bit surprised this happened so soon.

[888icb] 05/4/2017 07:33

RNS FFWD has disposed of its interest in Blue Star realising a profit of £188000 on its original investment.

[lauders] 05/4/2017 01:49

Shock horror, a miracle has taken place! Intensity Therapeutics Inc., have released some news on their website:

Intensity’s Chief Executive Officer Lewis H. Bender explained, “The direct killing action and immune response data generated in rodent models from our lead drug INT230-6 are impressive. We hope these animal results translate into an equally potent response in our clinical study, IT-01 for INT230-6, which is now recruiting patients in both the U.S. and Canada. Should the protective T cell immunity occur in humans, then INT230-6 could represent an important advance in the treatment of certain solid tumor cancers, potentially providing oncologists with a less toxic means to destroy visible tumors, eliminate metastases and prevent disease recurrence.”



Although animal testing is something I don't like this may be a way to transform cancer treatment & if any of my family and friends had a chance to be cured by this research then I think it is worth the small investment I have. Luckily none have cancer at the moment by the way, just if the unthinkable were to happen!

I also note that Leap have redeemed themselves and updated their website. Still took slightly too long ;-)

I can sense an investee update RNS coming along. Whether it will help the share price is another matter entirely!

[backtogo] 04/4/2017 16:57

yeah going down. last one out switch the lights off